Trials / Completed
CompletedNCT00220220
Amlodipine as add-on to Olmesartan in Hypertension
Efficacy and Safety of Amlodipine Used as add-on Therapy in Moderately to Severely Hypertensive Patients Not Adequately Controlled by Olmesartan Medoxomil 20 mg Monotherapy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 429 (estimated)
- Sponsor
- Sankyo Pharma Gmbh · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Test the efficacy and safety of the combination of olmesartan and amlodipine in hypertensive patients whose blood pressure is not adequately controlled with olmesartan alone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | olmesartan medoxomil | |
| DRUG | amlodipine |
Timeline
- Start date
- 2005-04-01
- Completion
- 2007-04-01
- First posted
- 2005-09-22
- Last updated
- 2018-12-24
Locations
6 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT00220220. Inclusion in this directory is not an endorsement.